Health News Releases

January 20, 2020 23:00

ResMed Introduces AirFit F30i, Its First Tube-up Full Face CPAP Mask

ResMed (NYSE: RMD) (ASX: RMD) today introduced AirFit F30i, its first tube-up full face CPAP mask, rounding out the most complete full face mask portfolio on the market. Full face CPAP users can no

January 20, 2020 10:37

Tej Kohli Foundation Moves One Step Closer to the Regeneration of Corneal Tissue to Cure Blindness

The Tej Kohli Foundation has moved one step closer to a non-surgical treatment for corneal blindness as it prepares to enter into a collaboration with researchers in Montreal, Canada and Moorfields Ey

January 17, 2020 08:44

OncoSec Board Rejects Alpha Holdings “Proposal” and Announces New Special Meeting Date

OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today announced that its Board of Directors (the “Board”)

January 16, 2020 09:50

AMR Life Science Industry 2020 Report: Successes and Setbacks in Fighting Superbugs

AMR Industry Alliance report released today provides a unique snapshot of the life science industry’s collective efforts in delivering on their commitments to tackle the rise of antimicrobial resistan

January 15, 2020 15:11

Takeda to Outline Progress on Business Transformation and Priorities at the 38th Annual J.P. Morgan Healthcare Conference

Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) will provide an update on the progress of its business transformation and priorities today at the 38th Annual J.P. Morgan Healthc

January 15, 2020 13:49

Covetrus Enters Into Definitive Agreement to Divest scil animal care to Heska

Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, today announced that it has entered into a definitive agreement to sell its scil animal care business (“scil”) to Hes

January 15, 2020 09:06

GNT Pharma‘s Anti-dementia Drug ’crisdesalazine' Demonstrates Efficacy in Phase III Clinical Study with Companion Dogs with Dementia

GNT Pharma has successfully completed a Phase III clinical trial for crisdesalazine, a new drug for treating canine cognitive dysfunction syndrome or Alzheimer’s disease. In the clinical study cond

January 14, 2020 11:45

BLEED OUT Documentary Screening and Panel Discussion

Patient Safety Movement Foundation: WHAT: After a routine partial hip replacement operation leaves his mother in a coma with permanent brain damage, a son’s video diary becomes a citizen’s inves

January 14, 2020 08:58

Study Shows HK L-137 Reduces Inflammation in Healthy Overweight Individuals — Takes Front Line Against Metabolic Syndrome

There’s a reason why the health-conscious focus has turned toward foods, supplements and behaviors to reduce inflammation. It’s why House Wellness Foods has put decades of meticulous research into the

January 13, 2020 09:35

Terns Pharmaceuticals Presents Results From An Ongoing Phase 1 Clinical Trial of TERN-201, a SSAO Inhibitor in Development for NASH

Terns Pharmaceuticals, Inc., a global biopharmaceutical company focused on discovering and developing innovative therapies to treat non-alcoholic steatohepatitis (NASH) and cancer, today announced the

January 10, 2020 09:45

Serum Institute and Aragen Bioscience Announce Collaboration on Vaccine Development

Aragen Bioscience, Inc, a subsidiary unit of GVK BIO and one of the leading pre-clinical CRO specializing in monoclonal antibody and other large-molecule product development and Serum Institute of Ind

January 10, 2020 08:38

Boehringer Ingelheim Partners with Enleofen to Develop First-in-Class Anti-IL-11 Therapies for a Range of Fibrotic Diseases

Boehringer Ingelheim and Enleofen Bio Pte. Ltd. (Enleofen) announced today the acquisition of worldwide exclusive rights to Enleofen’s preclinical interleukin-11 (IL-11) platform by Boehringer Ingelhe

January 09, 2020 13:39

Covetrus Announces Changes to Senior Management Team

Covetrus™ (NASDAQ: CVET), a global leader in animal-health technology and services, today announced several changes to its senior management and regional leadership teams. Effective January 7, 2020

January 09, 2020 11:50

Patient Safety Movement Foundation Launches ifyouvebeenharmed Website

Now there’s a website for patients and families that have experienced harm from medical errors: ifyouvebeenharmed.org. Launched by the Patient Safety Movement Foundation (PSMF), the site provides reso

January 08, 2020 16:50

Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Corporation (NEC; TOKYO: 6701), a leader in IT and network

January 07, 2020 10:30

OncoSec Sends Letter to Shareholders Highlighting that Both Leading Independent Proxy Advisory Firms - ISS and Glass Lewis - Have Recommended That OncoSec Shareholders Vote “FOR” the CGP/Sirtex Transaction on the WHITE Proxy Card

OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today issued the following letter to its shareholders. Th

December 31, 2019 11:48

WELT Smart Belt Pro Wins CES 2020 Innovation Award

WELT, a digital healthcare company, won the Innovation Awards for its new product, Smart Belt Pro, at CES 2020, the world’s largest consumer appliance fair, which is held in January 2020. An update

December 27, 2019 09:41

Institutional Shareholder Services Inc. (“ISS”) Recommends OncoSec Shareholders Vote “FOR” the CGP/Sirtex Transaction

OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today announced that Institutional Shareholder Services I

December 24, 2019 13:56

Invicro LLC Announces Dr. Matthew Silva as New Chief Executive Officer and Dr. Jack Hoppin is Named President of Konica Minolta Precision Medicine

Invicro LLC, a Konica Minolta company, today announces, Dr. Matthew Silva has been appointed as the new Chief Executive Officer. Dr. Silva will assume the day-to-day leadership responsibilities of the

December 23, 2019 11:00

OncoSec Responds to Alpha’s “Proposal”

OncoSec Medical Incorporated (NASDAQ:ONCS), (the “Company” or “OncoSec”) today issued the following response to the latest press release from Alpha Holdings, Inc. (Alpha): “Throughout its campaign

December 23, 2019 10:28

OncoSec Releases Presentation Spotlighting the Benefits of the Proposed CGP/Sirtex Transaction and Partnership

OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today announced the release of a detailed presentation hi

December 20, 2019 14:25

Masimo and Dräger Expand Licensing Agreement to Add Masimo Brain Monitoring and Capnography Technologies

Masimo (NASDAQ: MASI) and Dräger (OTCMKTS: DRWKF) announced today that they have expanded their partnership, whereby Dräger will integrate additional Masimo measurement technologies into Dräger’s fami

December 18, 2019 16:55

FerGene Appoints David Meek President and Chief Executive Officer

FerGene, a new gene therapy company launched by Ferring Pharmaceuticals and Blackstone Life Sciences in November, today announced the appointment of David Meek as President and Chief Executive Officer

December 18, 2019 13:45

Shandong Fontacea Announces License Agreement with Janssen to Develop and Commercialize Anti-IL17A Monoclonal Antibody

Shandong Fontacea Pharmaceutical Co. Ltd. (“Fontacea”) announced today that it has entered into an exclusive license, development and commercialization agreement with Janssen Biotech, Inc., to develop

December 17, 2019 15:57

Covetrus Announces Leadership Changes, Reaffirms 2019 Financial Guidance

Covetrus™ (NASDAQ: CVET), a global leader in animal-health technology and services, today announced that Stuart B. Gleichenhaus has been named interim chief financial officer, effective December 16, 2

News by Region

News by Industry